Your browser doesn't support javascript.
loading
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu, Wei-Fan; Lai, Hsueh-Chou; Chen, Cheng-Kuo; Wang, Hung-Wei; Chuang, Po-Heng; Tsai, Ming-Hung; Chen, Sheng-Hung; Chu, Chia-Sheng; Su, Wen-Pang; Chou, Jen-Wei; Kao, Jung-Ta; Chen, Hung-Yao; Chuang, Shih-Chieh; Tsai, Tsung-Yu; Hsiao, Wang-De; Huang, Guan-Tarn; Peng, Cheng-Yuan.
Afiliación
  • Hsu WF; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Lai HC; Graduate Institute of Biomedical Science, China Medical University Taichung, Taiwan.
  • Chen CK; School of Chinese Medicine, China Medical University Taichung, Taiwan.
  • Wang HW; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Chuang PH; School of Chinese Medicine, China Medical University Taichung, Taiwan.
  • Tsai MH; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Asia University Hospital Taichung, Taiwan.
  • Chen SH; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Chu CS; School of Medicine, China Medical University Taichung, Taiwan.
  • Su WP; Division of Gastroenterology, Department of Internal Medicine, Jen-Ai General Hospital Taichung, Taiwan.
  • Chou JW; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Kao JT; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Chen HY; School of Medicine, China Medical University Taichung, Taiwan.
  • Chuang SC; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Tsai TY; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Hsiao WD; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Huang GT; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
  • Peng CY; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital Taichung, Taiwan.
Am J Cancer Res ; 13(2): 654-668, 2023.
Article en En | MEDLINE | ID: mdl-36895987
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos